RT @AurelieRheumo: Risk of haematological malignancy in PsA Nordic cohorts *40 events, IR 67/100 000 person-years *NO di
Tweet Content
Risk of haematological malignancy in PsA
Nordic cohorts
*40 events, IR 67/100 000 person-years
*NO difference between PsA bionaive and TNFi treated
BUT *⬆️ in PsA vs. matched controls
*no difference between myeloid and lymphoid malignancies.
OP0257 #EULAR2022 @RheumNow https://t.co/oIojobgDP3
Show on Archive Page
On
Display in Search Results
On
PDQ
Off